Cargando…
Predicting Bevirimat resistance of HIV-1 from genotype
BACKGROUND: Maturation inhibitors are a new class of antiretroviral drugs. Bevirimat (BVM) was the first substance in this class of inhibitors entering clinical trials. While the inhibitory function of BVM is well established, the molecular mechanisms of action and resistance are not well understood...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224585/ https://www.ncbi.nlm.nih.gov/pubmed/20089140 http://dx.doi.org/10.1186/1471-2105-11-37 |